CooperCompanies Announces Release Date for First Quarter 2026
CooperCompanies (Nasdaq: COO) will report first quarter 2026 financial results on Thursday, March 5, 2026 at 4:15 PM ET.
Rhea-AI Summary
CooperCompanies (Nasdaq: COO) will report first quarter 2026 financial results on Thursday, March 5, 2026 at 4:15 PM ET. A conference call will follow at 5:00 PM ET with dial-in 800-715-9871 (conference ID 6529381). A live audio webcast and replay are available at the company investor website.
Positive
- None.
Negative
- None.
Details
News Market Reaction – COO
In the Feb 6 session, COO gained 2.50%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Earnings release date
- March 5, 2026
- Q1 2026 financial results release scheduled
- Release time
- 4:15 PM ET
- Q1 2026 results publication time
- Conference call time
- 5:00 PM ET
- Post-release Q1 2026 conference call
- Dial-in number
- 800-715-9871
- Investor conference call access number
- Conference ID
- 6529381
- Investor call conference identifier
- Current price
- $80.92
- Pre-news close relative to Q1 2026 release notice
- 52-week high
- $97.2119
- Upper end of 52-week trading range
- 52-week low
- $61.775
- Lower end of 52-week trading range
Historical Context
-
J.P. Morgan Healthcare Conference presentation and webcast availability details.
-
New independent director and cooperation agreement with Browning West.
-
New Board Chair and formal strategic review with focus on buybacks.
-
Q4 and fiscal 2025 results plus fiscal 2026 revenue, EPS and FCF guidance.
-
Scheduled Q4 and full-year 2025 results release and conference call details.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN RAMON, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today it will report first quarter 2026 financial results on Thursday, March 5, 2026, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.
The dial-in number for the call is 800-715-9871 and the conference ID is 6529381. A simultaneous audio webcast and subsequent replay can be accessed at http://investor.coopercos.com.
About CooperCompanies
CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on helping people experience life’s beautiful moments through its two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, helping to improve the way people see each day. CooperSurgical is a leading fertility and women’s healthcare company dedicated to putting time on the side of women, babies, and families at the healthcare moments that matter most. Headquartered in San Ramon, CA, CooperCompanies has a workforce of more than 15,000, sells products in over 130 countries, and positively impacts over fifty million lives each year. For more information, please visit www.coopercos.com.
Contact:
Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
ir@cooperco.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.